INTRODUCTION
============

Precise coordination between correct pre- and post-synaptic partners in the nervous system is important for its normal functions in both vertebrates and invertebrates. Synaptic contacts between neurons are established during the embryonic period as differentiating neurons navigate through the extracellular environment and locate their appropriate targets (see [@b18-molce-40-2-151] for a recent review). As a presynaptic neuron approaches its postsynaptic target, an individual presynaptic axon is defasciculated from an axon bundle consisting of multiple axons that travel together toward their specific target to form a synapse.

A number of studies have been performed in the last few decades to unravel the identities of proteins that are critical for specific coordination between pre- and post-synaptic partners ([@b18-molce-40-2-151]). Recently, it has been suggested that dysfunction in these critical components may underlie the pathogenesis of various neuropsychiatric diseases, including schizophrenia, bipolar disorder, and autism spectrum disorder (ASD), affecting a significant fraction of the world's population. For example, schizophrenia-associated mutations in reelin (RELN) and disrupted in schizophrenia1 (DISC1) can cause defects in neuronal migration ([@b33-molce-40-2-151]), dendritic organization, and remodeling of synapses ([@b4-molce-40-2-151]). In addition, protocadherin 12 (PCDH12) linked to schizophrenia ([@b25-molce-40-2-151]) has been implicated in neuronal differentiation and synaptogenesis ([@b32-molce-40-2-151]). In line with these findings, another report has suggested the possibility of neuropsychiatric diseases associated with genetic perturbations in the cell adhesion molecule (CAM) pathway, including NRXN1, CNTNAP, and CASK ([@b49-molce-40-2-151]).

Among the major neuropsychiatric disorders, ASD is characterized by defects in social communication and language development as well as restricted and repetitive behaviors that develops by the age of three ([@b1-molce-40-2-151]; [@b50-molce-40-2-151]; [@b64-molce-40-2-151]). The clinical aspects for diagnosis and behavioral treatments of ASD have been mostly considered in the earlier studies, but a greater attention is now being given to genetic abnormalities that could potentially contribute to the development of ASD. Due to its complex nature, as suggested by multi-layered genetic interactions (see [@b15-molce-40-2-151] for a recent review), it is very difficult to delineate individual candidate genes and relevant molecular pathways of which defects may underlie the pathogenesis of ASD. Recent attempts to elucidate such complex genetic contributions to ASD have employed population- and genome-based analyses, including linkage studies and genomic-wide association studies. As a result, novel genetic components have been identified, ranging from individual genes to chromosomal regions encompassing multiple genes ([@b15-molce-40-2-151]). Important outcomes of these genome-based studies in patients with ASD include significant correlations with repetitive deletion or duplication of specific chromosomal regions that leads to changes in the copy number of genes enclosed in the region, called copy number variations (CNVs). Indeed, CNVs at multiple chromosomal loci, including 2p16.3, 3p26.c, 15q11-q13, 16p11.2, and 22q13.33, appear to have strong associations with ASD ([@b54-molce-40-2-151]).

Among these CNV loci, frequent deletion or duplication events in the 16p11.2 region have been linked to ASD and schizophrenia in a series of familial studies ([@b36-molce-40-2-151]; [@b43-molce-40-2-151]; [@b47-molce-40-2-151]; [@b62-molce-40-2-151]). Furthermore, these events have been estimated to be responsible for up to 1% of ASD cases according to a previous study (5 out of 512 children) ([@b62-molce-40-2-151]). The 16p11.2 locus includes 27 annotated genes within an approximately 500Kb segment ([@b29-molce-40-2-151]; [@b48-molce-40-2-151]), many of which have been implicated in neural development ([@b22-molce-40-2-151]; [@b36-molce-40-2-151]; [@b45-molce-40-2-151]). A recent study using a zebrafish model has demonstrated significant structural abnormalities induced by defects in zebrafish genes homologous to human counterparts at the 16p11.2 locus, including a change in brain size and eye structure as well as formation of abnormal axonal tracts ([@b11-molce-40-2-151]). In addition, dysfunction of extracellular signal--regulated kinase 1 (ERK1) encoded by *mitogen-activated protein kinase 3* (*MAPK3*) located within this region leads to changes in brain size and cortical cytoarchitecture in a murine model system ([@b48-molce-40-2-151]). Taken together, these data suggest critical roles of ASD-linked genes localized at the 16p11.2 locus in precise regulation of neural development. Despite these recent efforts, the specific contributions of individual genes to the development of neural circuits remain poorly understood.

We have recently conducted a RNAi-based genetic screen using *Drosophila melanogaster* to analyze contributions of individual genes in the 16p11.2 region to synaptic morphology ([@b46-molce-40-2-151]). The *Drosophila* neuromuscular junction (NMJ) is one of the most well characterized glutamatergic model systems that provides a unique opportunity to systematically study structural and functional abnormalities induced by genetic perturbations at well-defined and stereotypic synapses ([@b5-molce-40-2-151]; [@b28-molce-40-2-151]; [@b31-molce-40-2-151]; [@b44-molce-40-2-151]). Taking advantage of this system, we monitored the presence of aberrant synaptic architecture, such as errors in presynaptic nerve innervation and formation of synaptic boutons. As a result, we found abnormal innervation patterns and premature defasciculation of presynaptic motor axons in mutants defective in *Drosophila rolled* (*rl*), a gene homologous to human *MAPK3*. Further analyses revealed significant genetic interactions between *rl* and other genes, of which protein products were expected to interact with Rolled MAPK3 according to a proteomic study ([@b21-molce-40-2-151]), and a central role of *rl* in this genetic network. Together with previous reports using zebrafish and murine models, our results provide another line of evidence to support the idea that Rolled MAPK3 plays an important role in regulating neuronal architecture and the hypothesis that such structural defects during development may underlie the pathogenesis of ASD.

MATERIALS AND METHODS
=====================

Fly stocks
----------

All crosses and stocks were raised on standard media at 24°C with 45%--60% humidity. The Canton-S and *w^1118^* strains were used as wildtype (WT) controls. All fly stocks used in our study obtained from Bloomington Drosophila Stock Center include: 1) *rl^1^* for *rolled* (*rl*); 2) *w^\*^; Cdk2^3^/TM3, Sb^1^* *P{35UZ}2*, *y^1^* *sc^\*^* *v^1^; P{TRiP.GL00162}attP2* and *y^1^* *sc^\*^* *v^1^; P{TRiP. GL00611}attP40* for *cyclin-dependent kinase 2 (Cdk2)*; 3) *cn^1^* *Gα~q~^1^* and *w^\*^; P{w\[+mC\]=UAS-Gα~q~. dsR-NA.1f1}2/CyO, P{w\[+mC\]=ActGFP}JMR1* for *G-protein αlpha-q subunit* (*Gα~q~*); 4) *y^1^* *w^67c23^; P{EPgy2}Gp93^EY06213^* and *y^1^* *sc^\*^* *v^1^; P{TRiP. HMS01334}attP2* for *glycoprotein 93* (*Gp93*). The *elav^c155^-GAL4* and *mef2-GAL4* drivers based upon the GAL4-UAS system ([@b16-molce-40-2-151]) were used for expression of neuron- and muscle-specific dsRNA (RNAi) lines, respectively. *y^1^* *v^1^; P{CaryP}attP2* and *y^1^* *v^1^; P{CaryP}attP40* were used as controls, along with *UAS-rl^+^* (*w^1118^; P{UAS-rl.K}2A*) as a transgenic line carrying the WT gene. Whenever possible, we used multiple RNAi lines and mutant alleles for each gene to confirm the effect of RNA interference and mutations and combined the results from multiple variants since they showed similar trends, albeit slight differences in the severity of their phenotypes.

Immunohistochemistry
--------------------

Male third instar larvae were dissected in 1X Phosphate-buffered saline (PBS) and prepared for immunofluorescent staining, as previously described ([@b38-molce-40-2-151]). The morphology of neuromuscular junctions (NMJs) was visualized with Alexa 594-conjugated goat anti-HRP antibody (1:250; Jackson ImmunoResearch Laboratories, USA). For direct comparison of absolute FasII density among *rl, Cdk2, Gα~q~* and *Gp93* mutants as well as WT, the samples were simultaneously treated for immunofluorescent staining in the same tube and incubated with anti-FasII (1D4) antibody (at 1:100; Developmental Studies Hybridoma Bank, USA) followed by Alexa 488-conjugated goat anti-mouse antibody (at 1:400; Jackson ImmunoResearch Laboratories).

Image analysis
--------------

The Z-stack images of body-wall muscles 12 (M12) and 13 (M13) were obtained from the abdominal segments A2 - A3 using a confocal microscope (Zeiss, LSM700; Carl Zeiss, Germany) and processed with ZEN software (Carl Zeiss). The pattern of axonal targeting was monitored in M13 that is normally innervated with type Ib, Is and II axon branches, but not with type III axons. These types of axon branches innervate target muscles by forming synaptic boutons of different sizes and shapes ([@b5-molce-40-2-151]). The presence of synaptic boutons originating from type III axons was counted as an ectopic innervation of type III axons at a specific synapse. The frequency or the ratio of ectopic type III axon innervations at M13 NMJs (the number of M13 NMJs with ectopic type III synaptic boutons over total number of NMJs examined) was then calculated for each genotype for further analyses. In addition, the defasciculation status of axonal bundles was monitored at the boundary of M13 and M12. The premature defasciculation was then defined as early separation of axon fibers within a single axon bundle before it made contact with M12. The frequency or the ratio of premature defasciculation (the number of NMJs with premature defasciculation over total number of NMJs examined) was then calculated for each genotype for further analyses.

For direct comparison of FasII immunoreactivities, the same confocal scanning protocols were applied to all samples that were treated together in the same tube during an immunostaining procedure. The FasII density was then measured as pixel intensity from at least six type Ib synaptic boutons innervating muscle 12 and connecting axon braches using the ImageJ package (NIH, USA).

qRT-PCR analysis
----------------

Total RNA was extracted from heads of WT and mutant flies using RNeasy Mini Kit (QIAGEN Korea Ltd., Korea), followed by synthesis of cDNA from 2 μg of extracted RNA using QuantiTect Reverse Transcription Kit (QIAGEN). The real-time reverse transcription qPCR reaction (RT-qPCR) was performed using the SYBR Green qPCR master mix (Enzynomics, Korea) in a 96-well plate. The reaction cycles were initiated with a denaturation step (95°C for 10 min), followed by 40 cycles consisting of denaturation (95°C for 15 s), annealing (60°C for 20 s) and extension steps (72°C for 30 s). The RT-qPCR analysis was conducted using Applied Biosystems 7500 Real*-*Time PCR system (USA). The mRNA levels of *GAPDH* were measured as a reference for comparison. The primer sets used for RT-qPCR analyses include: forward 5′-GCAAGGGTGCGTCCTATGAT-3′ and reverse 5′--AGAGTGTGGGTGGGTAGTGT-3′ for *GAPDH*; forward 5′-CATGGTTGTGTCTGCGGATG-3′ and 5′-GCTTATGGCATGGTTGTG-TCTG-3′ and reverse 5′-AAGTTT-GGTGTTCAAAGGGCG-3′ and 5′-TTGGTGTTCAAAGGGC-GATA-3′ for two independent *rolled* sets; forward 5′--CAACCAGGTGGGATTAGGAA-3′ and reverse 5′--TAACG- CCCGGACAGTATTTG-3′ for total FasII ([@b8-molce-40-2-151]). Each RT-qPCR reaction was performed in triplicate. The relative gene expression level compared to control was calculated using the 2^−ΔΔCt^ method ([@b42-molce-40-2-151]). The results were summarized from at least three independent experiments.

Statistical analyses
--------------------

To compare the proportional differences in ectopic axon branches between two groups, the data were categorized in the 2 × 2 contingency tables (with phenotypes *vs.* without phenotypes in two groups) and subjected to Fisher's exact test. The RT-qPCR data from multiple genotypes were compared using one-way Analysis of Variance (ANOVA) followed by Tukey's post-hoc test. *P* values less than 0.05 were considered significant.

RESULTS
=======

Abnormal patterns of motor axon innervation and defasciculation in *rolled* mutants
-----------------------------------------------------------------------------------

CNVs at the 16p11.2 locus have been implicated in familial cases of ASD ([@b36-molce-40-2-151]; [@b43-molce-40-2-151]; [@b47-molce-40-2-151]; [@b62-molce-40-2-151]). However, the identities of the genes responsible for the pathological features of ASD linked to these CNVs are not well understood in experimental settings. To systematically investigate the roles of individual human genes in this region, we recently performed an RNAi-based genetic screen using *Drosophila melanogaster* ([@b46-molce-40-2-151]). The most striking abnormalities in this screen, including multiple and ectopic innervations of presynaptic motor axons into postsynaptic body-wall muscles, were detected in larvae expressing double-stranded RNA targeting *rl*, a gene homologous to human *MAPK3* at the 16p11.2 locus ([Supplementary Fig. S1](#s1-molce-40-2-151){ref-type="supplementary-material"}). To further confirm that these phenotypes were specifically induced by the loss of Rolled MAPK3, a mutational analysis was performed with a loss-of-function allele of the *rl* mutants (*rl^1^*). Consistent with the phenotypes induced by an RNAi-based knockdown approach, a mutation in *rl MAPK3* resulted in two distinct structural abnormalities at larval NMJs formed in the abdominal body-wall muscles ([Fig. 1](#f1-molce-40-2-151){ref-type="fig"}).

When innervation patterns of presynaptic motor axons were examined in muscles 13 (M13) and 12 (M12) of the abdominal body-wall musculature in WT and *rl* mutants, we found aberrant innervations of type III axons in *rl* larvae ([Fig. 1A](#f1-molce-40-2-151){ref-type="fig"}, middle panel). Unlike other motor axons transducing glutamatergic signals, the synaptic terminals of type III axons contain neuropeptides ([@b23-molce-40-2-151]; [@b24-molce-40-2-151]). Their postsynaptic target in WT animals is extremely restricted, mostly with a sole innervation into M12, but not in any other the body-wall musculature ([@b28-molce-40-2-151]) ([Supplementary Fig. S2](#s1-molce-40-2-151){ref-type="supplementary-material"}; see also [Fig. 1A](#f1-molce-40-2-151){ref-type="fig"}, left panel). In contrast, *rl* mutants often displayed innervations of type III axons into M13 and M12, as evidenced by the presence of type III synaptic boutons of a distinct shape and size ([Fig. 1A](#f1-molce-40-2-151){ref-type="fig"}, middle panel, arrows). To quantify the severity of this targeting error, we counted the frequency of ectopic innervation by type III axons in M13 of WT and *rl* mutants. As shown in [Fig. 1B](#f1-molce-40-2-151){ref-type="fig"}, the number of M13 NMJs with ectopic type III axons was significantly higher in *rl* mutants. In fact, the majority of *rl* NMJs displayed additional innervation of type III axons ([Fig. 1B](#f1-molce-40-2-151){ref-type="fig"} for the pooled data, 7.84% (8 of 102) for WT vs. 63.29% (50 of 79) for *rl*, *P* \< 0.001 for WT vs. *rl*; see [Supplementary Table S1A](#s1-molce-40-2-151){ref-type="supplementary-material"}).

In addition to such an aberrant innervation pattern in *rl* mutants, we observed premature defasciculation of presynaptic axon bundles near M12. The majority of axon bundles containing individual motor axons targeted to M12 remained fasciculated in WT until they traveled underneath M13 and finally reached the surface of M12 ([Fig. 1A](#f1-molce-40-2-151){ref-type="fig"}, left panel; see also [Supplementary Fig. S2](#s1-molce-40-2-151){ref-type="supplementary-material"}). However, we found that a significant fraction of these axons in *rl* mutants exited the bundles and were separated from each other before they made contact with M12 ([Fig. 1A](#f1-molce-40-2-151){ref-type="fig"}, right panel, arrowhead; [Fig. 1C](#f1-molce-40-2-151){ref-type="fig"} for the pooled data, 13.73% (14 of 102) for WT vs. 37.97% (30 of 79) for *rl*, *P* \< 0.001 for WT vs. *rl*; see [Supplementary Table S1B](#s1-molce-40-2-151){ref-type="supplementary-material"}). This is an interesting parallel to a previous study demonstrating reduced and disorganized axonal tracts induced by loss of MAPK3 in zebrafish embryos ([@b11-molce-40-2-151]). Thus, our results strongly suggest a potential contribution of Rolled MAPK3 to organization of presynaptic axon bundles and their proper targeting to postsynaptic targets.

Defective targeting of type III axons and premature defasciculation rescued with expression of WT Rolled in the mutant background
---------------------------------------------------------------------------------------------------------------------------------

Abnormal targeting of type III axons and premature defasciculation of axon bundles in *rl* mutants may result from defective MAPK3 signaling in either the pre- or post-synaptic compartment. To delineate the specific contributions of neuronal and muscular MAPK3 to proper targeting of these axons, we performed rescue experiments with pre- or post-synaptic expression of WT *rl* (*UAS*-*rl^+^*) in the *rl* mutant background using the GAL4-UAS system ([@b16-molce-40-2-151]). The *elav^C155^*- and *mef2-GAL4* drivers were used for specific expression of *rl^+^* in neuronal and muscular compartments, respectively. As a control, we first examined the effect of *rl* overexpression in the WT background. Larvae presynaptically overexpressing WT *rl* (*elav^C155^-GAL4→UAS-rl^+^*) did not differ from control groups (either *elav^C155^-GAL4* or *UAS-rl^+^* alone) in their innervation patterns of type III axons at M13 NMJs or in the defasciculation profiles of axon bundles at the border of M12 ([Supplementary Fig. S3](#s1-molce-40-2-151){ref-type="supplementary-material"}).

Then, we examined the effect of *rl* overexpression in the mutant background. As expected, a transgenic construct of WT *rl* alone (*UAS-rl^+^*) in the absence of a proper GAL4 driver was insufficient to induce any significant changes in synaptic abnormalities detected in the *rl* mutant background ([Fig. 2A](#f2-molce-40-2-151){ref-type="fig"}, top panels). The fraction of animals with aberrant type III innervation into M13 and premature axonal defasciculation before M12 remained high in *rl* mutants with no GAL4 driver ([Fig. 2B](#f2-molce-40-2-151){ref-type="fig"} for type III axons in M13, *P* \< 0.001 for WT vs. *rl^1^, UAS-rl^+^*; [Fig. 2C](#f2-molce-40-2-151){ref-type="fig"} for premature defasciculation, *P* \< 0.001 for WT vs. *rl^1^, UAS-rl^+^*). However, neuronal expression of WT *rl* in mutants led to a significant decrease in the fraction of type III axons targeted to M13, almost to the WT level ([Fig. 2A](#f2-molce-40-2-151){ref-type="fig"}, bottom left; [Fig. 2B](#f2-molce-40-2-151){ref-type="fig"}, *P* \< 0.01 for *rl^1^, UAS-rl^+^* vs. *elav^C155^-GAL4/Y*; *rl^1^, UAS-rl^+^*). On the other hand, the degree of rescue in premature defasciculation defects by neuronal expression of WT *rl* failed to reach statistical significance, albeit a tendency to diminish the mutant phenotype ([Fig. 2C](#f2-molce-40-2-151){ref-type="fig"}). In case of muscular expression of WT *rl*, the frequency of aberrant innervation of type III axons into M13 remained higher in mutants than that in the WT control ([Fig. 2B](#f2-molce-40-2-151){ref-type="fig"}, *P* \< 0.05 for WT vs. *rl^1^, UAS-rl^+^; mef2-GAL4/+*), but mutant phenotypes in both innervation and fasciculation patterns were significantly attenuated ([Fig. 2A](#f2-molce-40-2-151){ref-type="fig"}, bottom right; [Figs. 2B and 2C](#f2-molce-40-2-151){ref-type="fig"}, *P* \< 0.05 for *rl^1^, UAS-rl^+^* vs. *rl^1^, UAS-rl^+^; mef2-GAL4/+*), with a more striking effect on premature defasciculation ([Fig. 2C](#f2-molce-40-2-151){ref-type="fig"}).

Taken together, our results indicate significant contributions of both neuronal and muscular Rolled MAPK3 in finding a proper target for type III axons and tightly controlling axonal defasciculation. These data also suggest differential molecular mechanisms implicated in the regulation of proper synaptic connectivity and defasciculation events of axon bundles, both of which may involve MAPK3 activities.

Genetic interactions between MAPK3 and functionally linked proteins involved in aberrant targeting of type III axons
--------------------------------------------------------------------------------------------------------------------

A previous proteomic analysis has suggested strong functional links between Rolled MAPK3 and diverse classes of proteins, including cyclin-dependent kinase 2 (Cdk2), G-protein alpha-q (Gα~q~), and glycoprotein 93 (Gp93) ([@b21-molce-40-2-151]). It is possible that the activities of these functional networks coordinate proper targeting and defasciculation of motor axons. If that is the case, dysfunction of these network components other than Rolled MAPK3 would also lead to similar abnormalities observed in *rl* mutants. To test this idea, we performed genetic analyses using mutants defective in Cdk2, Gα~q~, and Gp93 and examined their synaptic morphology ([Fig. 3](#f3-molce-40-2-151){ref-type="fig"}). Due to the higher ratio of mutant phenotypes, we focused on an analysis of aberrant innervation patterns of type III axons in M13 of these mutants.

Importantly, ectopic type III axons in M13 were frequently detected in *Cdk2*, *Gα~q~*, and *Gp93* mutants ([Fig. 3](#f3-molce-40-2-151){ref-type="fig"}). To further confirm specific contributions of these molecules to the target selection process, synaptic morphology was monitored in transgenic animals with a RNAi-based knockdown of each gene ([Supplementary Table S2](#s1-molce-40-2-151){ref-type="supplementary-material"}). Significant changes in innervation patterns were only evident upon expression of dsRNA constructs against *Cdk2*, but not *Gα~q~* or *Gp93* ([Supplementary Table S2](#s1-molce-40-2-151){ref-type="supplementary-material"}). However, we observed a tendency for more frequent ectopic type III axons in some of these dsR-NA-expressing animals ([Supplementary Table S2](#s1-molce-40-2-151){ref-type="supplementary-material"}), supporting, in part, the possibility that these genes may play important roles in regulating proper targeting of motor axons, together with *rl.* It should be noted that the proportions of *Cdk2*, *Gα~q~* and *Gp93* mutants with abnormal innervation patterns were significantly lower than that of *rl* mutants ([Fig. 3B](#f3-molce-40-2-151){ref-type="fig"}), suggesting a dominant contribution of Rolled MAPK3 within these protein networks to proper synaptic target selection.

Our results demonstrating similar mutational phenotypes in mutants defective in Rolled MAPK3 as well as Cdk2, Gα~q~, and Gp93 suggest that they may interact with each other and thus participate in similar signaling pathways. We tested this idea by monitoring the presence of genetic interactions between *rl* and other genes among *Cdk2*, *Gα~q~*, and *Gp93* in double heterozygous combinations. When single heterozygous animals were analyzed for their phenotypes in type III innervation patterns, we found that *rl* heterozygotes (*rl^−/+^*) showed a slightly higher ratio of ectopic type III axons in M13. A similar, but lesser degree of increase in the ratio was also detected in *Gα~q~* and *Gp93* single heterozygotes (*Gα~q~^−/+^* and *Gp93^−/+^*) ([Fig. 4B](#f4-molce-40-2-151){ref-type="fig"}). Despite these unexpected increases in single heterozygous animals, some double heterozygous combinations, specifically *rl^−/+^; Cdk2^−/+^* and *rl^−/+^; Gp93^−/+^*, displayed an apparent increase in the ratio of ectopic type III innervation ([Figs. 4A and 4B](#f4-molce-40-2-151){ref-type="fig"}, *P* \< 0.05 for *Cdk2^−/+^* *vs. rl^−/+^; Cdk2^−/+^* and *P* \< 0.001 for *Gp93^−/+^* *vs. rl^−/+^; Gp93^−/+^*). In case of *rl* and *Gp93*, the ectopic innervation ratio measured in double heterozygous mutants (*rl^−/+^; Gp93^−/+^*) was much higher than that in either single heterozygote (*rl^−/+^* *or Gp93^−/+^*) or the combined ratio of the two heterozygotes ([Fig. 4B](#f4-molce-40-2-151){ref-type="fig"}), suggesting a clear synergistic interaction between *rl* and *Gp93*.

Transcriptional regulation of Rolled MAPK3 in mutants with ectopic innervation patterns of type III axons
---------------------------------------------------------------------------------------------------------

Our results described above demonstrate a critical role of Rolled MAPK3 and relevant protein networks in regulating the proper selection of synaptic targets. Based upon the phenotypic similarities in mutants and the presence of genetic interactions, it is plausible that reduced activity of Rolled MAPK3 may underlie expression of the consistent mutant phenotypes we observed. We verified this idea by analyzing the level of the *rl* transcript in *Cdk2*, *Gα~q~*, and *Gp93* mutants with a RT-qPCR assay. WT and *rl* animals were included in the set as a negative and positive control, respectively. When the mRNA levels of the reference housekeeping gene *glyceraldehyde-3-phosphate dehydrogenase* and *rl* were measured using two independent *rl* primers (sets 1 and 2), consistent and significant downregulation of *rl* transcripts was evident in *Cdk2*, *Gα~q~*, and *Gp93* mutants, similar to the phenotype observed in *rl* mutants ([Figs. 5A and 5B](#f5-molce-40-2-151){ref-type="fig"}, *P* \< 0.001 for WT vs. *rl*, *Gα~q~* or *Gp93* and *P* \< 0.01 for WT vs. *Cdk2*). These results parallel the potential genetic interactions indicated by the enhanced mutant phenotypes of ectopic type III axons in the double heterozygous combinations ([Fig. 4B](#f4-molce-40-2-151){ref-type="fig"}), further confirming a central role for Rolled MAPK3 in regulating innervation patterns of type III axons.

It has been suggested that Rolled MAPK3 regulates the expression of fasciclin II (FasII) at *Drosophila* larval NMJs ([@b34-molce-40-2-151]). FasII, a *Drosophila* homolog of human neuronal cell adhesion molecule (NCAM), plays a critical role in regulating various aspects of synaptic development, including axonal pathfinding and fasciculation as well as synaptic growth, via its homophilic interactions between pre- and post-synaptic compartments ([@b41-molce-40-2-151]; [@b52-molce-40-2-151]; [@b53-molce-40-2-151]). Based on these findings, we examined whether the *fasII* transcript level was altered in mutants using a primer specific to total *fasII* RNA ([@b8-molce-40-2-151]). Among those screened, the *Gα~q~* and *Gp93* mutants displayed a slight, but significant downregulation of total *fasII* transcripts ([Fig. 5C](#f5-molce-40-2-151){ref-type="fig"}; *P* \< 0.05 and *P* \< 0.01, WT vs. *Gα~q~* and *Gp93*, respectively). However, we failed to detect transcriptional changes in *fasII* induced by an *rl* mutation ([Fig. 5C](#f5-molce-40-2-151){ref-type="fig"}), inconsistent with a previous report suggesting a functional link between Rolled MAPK3 and FasII ([@b34-molce-40-2-151]). Furthermore, direct comparisons of FasII immunoreactivity at larval NMJs did not yield noticeable differences in its distribution among the mutants screened ([Supplementary Table S3](#s1-molce-40-2-151){ref-type="supplementary-material"}). Taken together, these results demonstrating discrepancies in transcriptional regulation of *fasII* among mutants with similar structural abnormalities suggest a minimal contribution by FasII to Rolled MAPK3-associated protein networks and the presence of unknown molecular mechanisms responsible for ensuring proper selection of synaptic partners via Rolled MAPK3-dependent pathways.

DISCUSSION
==========

Recent studies on ASD have revealed an important link to CNVs at multiple genomic loci ([@b54-molce-40-2-151]). In the present study, we investigated the roles of individual genes at the 16p11.2 locus, one of the CNV spots frequently mapped to ASD, in the regulation of synaptic architecture. We took advantage of the stereotypic and identifiable *Drosophila* larval NMJs, a well-established synaptic model system. Our results indicate defects in nerve innervation patterns and fasciculation of axon bundles induced by a mutation in *Drosophila rl* homologous to human *MAPK3* ([Fig. 1](#f1-molce-40-2-151){ref-type="fig"}). Similar phenotypes were observed in mutants defective in other proteins that are expected to functionally interact with MAPK3, including Cdk2, Gα~q~, and Gp93 ([Fig. 3](#f3-molce-40-2-151){ref-type="fig"}). In line with this result, genetic interactions between *rl* and some of these genes were revealed in double heterozygous mutant combinations ([Fig. 4](#f4-molce-40-2-151){ref-type="fig"}). Finally, downregulation of *rl* transcripts was consistently detected in *Cdk2*, *Gα~q~*, and *Gp93* mutants, almost comparable to reduced transcript levels in *rl* mutants themselves ([Fig. 5](#f5-molce-40-2-151){ref-type="fig"}). Taken together, these results point toward a central role for Rolled MAPK3 in proper targeting of axons and thus selection of synaptic partners via the activity of a MAPK3-associated protein network.

Abnormal neuronal architecture and its implication in neuropsychiatric disorders
--------------------------------------------------------------------------------

Recent multi-directional research efforts have yielded significant advances in our understanding about the pathophysiology of neuropsychiatric disorders, including schizophrenia, major depression and ASD. As a result, greater attention has been given to the potential involvement of structural abnormalities in the nervous system ([@b2-molce-40-2-151]; [@b4-molce-40-2-151]). For example, macroscopic post-mortem analyses of the brain from patients with schizophrenia revealed a significant reduction in its volume, particularly in the areas of the posterior superior temporal gyrus, amygdalahippocampal complex and hippocampus ([@b55-molce-40-2-151]; [@b63-molce-40-2-151]). In addition to a gross change in brain size, microscopic changes at the level of individual neurons, such as a decrease in the number and volume of dendritic spines, have been reported in the CA3 region of the hippocampus in patients with schizophrenia ([@b35-molce-40-2-151]). Similar microscopic changes were also evident in patients with a mood disorder ([@b37-molce-40-2-151]), along with a reduced density of pyramidal neurons and glia in the CA regions of the hippocampus ([@b56-molce-40-2-151]).

In line with these reports, a body of experimental evidences supports the idea that structural abnormalities in the nervous system confer susceptibility to ASD (see [@b2-molce-40-2-151] for a recent review). Indeed, anatomical differences in several neurocognitive networks have been reported in patients with ASD ([@b20-molce-40-2-151]), including greater brain size and enhanced neuronal proliferation in the prefrontal cortex as well as disrupted cellular architecture in the cerebellar cortex ([@b7-molce-40-2-151]; [@b19-molce-40-2-151]). Furthermore, brain imaging studies have revealed atypical white- and gray-matter connectivity ([@b20-molce-40-2-151]), in line with our results demonstrating abnormal synaptic targeting induced by a mutation in the gene located at an ASD-mapped CNV locus. Taken together, these results demonstrate consistent structural abnormalities in patients suffering from neuropsychiatric disorders and provide useful insights into our understanding of their pathophysiology.

The role of MAPK3 in regulation of synaptic connectivity
--------------------------------------------------------

While a strong association has been suggested between abnormal neuronal architecture and susceptibility to ASD, the underlying molecular networks involving protein-protein interactions remain poorly understood. In this study, we demonstrated abnormal axonal innervation caused by a mutation in *rl MAPK3* located at the ASD-mapped 16p11.2 locus and revealed a potential protein network that may participate in controlling proper synaptic target selection.

*Drosophila* MAPK encoded by *rl* is a protein homologous to human ERK1 encoded by *MAPK3* at the 16p11.2 locus ([@b10-molce-40-2-151]). ERK1 is a serine/threonine kinase that shares approximately 84% of its sequence with ERK2, another ERK isoform ([@b13-molce-40-2-151]; [@b14-molce-40-2-151]). ERK1/2 is involved in various aspects of neural development, ranging from neurogenesis to synaptic plasticity underlying learning and memory ([@b57-molce-40-2-151]). Loss of ERK1/2 activity leads to alterations in the cortical lamina composition along with abnormal neuronal morphology in the cortex and dentate gyrus in mice ([@b48-molce-40-2-151]; [@b60-molce-40-2-151]). The expression of *Drosophila* MAPK3 encoded by *rl* has also been reported previously in synaptic boutons at larval NMJs, where it interacts with other synaptic proteins, including FasII, to regulate the number of synaptic boutons (Ko et al., 2002). Studies in murine models and patients with ASD have revealed abnormal upregulation of ERK1/2 signaling activities associated with significant changes in neuronal migration, synapse formation, and maturation of dendritic spines, further confirming a critical role of MAPK in neural development.

In our study, we present a novel phenotype of altered synaptic architecture, including ectopic targeting of presynaptic axons to unnatural postsynaptic partners and early defasciculation of commonly traveling axon bundles that are frequently observed following loss of MAPK3 activity in *Drosophila*. Establishment of precise neural connectivity is crucial for maintaining proper function of the nervous system and requires molecular machinery determining synaptic specificity ([@b18-molce-40-2-151]; [@b58-molce-40-2-151]). Considering the expression of MAPK/ERK at WT synapses and its abnormal regulation observed in ASD patients, we hypothesize that MAPK3 located at the 16p11.2 locus is a part of the cellular signaling pathways responsible for synaptic specificity and thus for establishing proper neural connectivity. If our hypothesis holds true, dysfunction of MAPK3 could cause significant disturbances in circuit connectivity eventually leading to alterations in neural function, thus predisposing individuals to ASD.

MAPK3-associated protein network in regulation of synaptic connectivity
-----------------------------------------------------------------------

In addition to Rolled MAPK3, our results shown in [Fig. 4](#f4-molce-40-2-151){ref-type="fig"} suggest contributions of other molecules presumably linked to MAPK3, including Cdk2, Gα~q~, and Gp93 ([@b21-molce-40-2-151]), to specific targeting of presynaptic axons. Cdk2 is a serine/threonine kinase that is important for controlling the cell cycle and thus proliferation by modulating the G1/S transition phase ([@b59-molce-40-2-151]). When Cdk2 forms a complex with MAPK in the cytoplasm, activation of MAPK induces translocation of this complex into the nucleus, allowing Cdk2 to regulate transition of the cell cycle from the G1 to the S phase in mammalian cells ([@b12-molce-40-2-151]; [@b61-molce-40-2-151]). However, whether Cdk2 activity is required during neural development other than the stage of neurogenesis remains unclear. Thus, the significance of the functional interaction between MAPK3 and Cdk2 in the regulation of neuronal architecture awaits further investigation.

Gα~q~, a part of the α subunits of G proteins, activates phospholipase Cβ that hydrolyzes PIP~2~ and eventually to diacylglycerol and inositol-1,4,5-triphosphate (see [@b51-molce-40-2-151] for a recent review). In addition to a potential correlation between Gα~q~ activity and other neuro-psychiatric disorders such as schizophrenia ([@b39-molce-40-2-151]), a recent report indicated a significantly altered *Gα~q~* transcript level in children with ASD ([@b30-molce-40-2-151]). However, apart from the finding that MAPK3 is downstream of Gα~q~ ([@b51-molce-40-2-151]), our knowledge about Gα~q~ signaling-dependent regulation of MAPK3 activity in the nervous system is extremely limited.

Among various proteins that are potentially linked to MAPK3, our genetic analysis indicates an apparent synergistic interaction between *rl* and *Gp93* compared to *Cdk2* and *Gα~q~* ([Fig. 4B](#f4-molce-40-2-151){ref-type="fig"}). *Drosophila* Gp93 is an ortholog of mammalian Gp96, a heat shock protein that functions as a chaperone responsible for surveillance, and is mostly implicated in carcinogenesis and inflammation (see [@b3-molce-40-2-151] for a recent review). Gp93 localizes in the growth cone and synaptosome in the rat brain during the early postnatal period ([@b26-molce-40-2-151]; [@b40-molce-40-2-151]). Assuming that proper selection of synaptic targets and axonal pathfinding requires precise communication between presynaptic growth cones and their natural targets as well as extracellular guidance cues, it is intriguing to speculate that MAPK3 interacts with Gp93 to control target selection processes at synapses.

Despite the differential degrees of genetic interactions between *rl* and its potential partners, our RT-qPCR analysis demonstrated consistent downregulation of *rl* transcripts in all mutants screened. Transcriptional activity of MAPK3 is suppressed when cells are placed under growth arrest or hypoxic conditions ([@b27-molce-40-2-151]). At this moment, it remains elusive whether such transcriptional suppression is correlated with the activities of MAPK3-related protein network described above or with the process of synaptic formation via selection of proper targets. Further studies will be required to elucidate the molecular mechanisms that induce transcriptional regulation of MAPK3 during synaptic development.

Molecular targets regulated by the MAPK3-related protein network to influence synaptic connectivity
---------------------------------------------------------------------------------------------------

A previous report in *Drosophila* has suggested a MAPK3-dependent regulation of FasII expression at synapses ([@b34-molce-40-2-151]). Considering the tight association between FasII level and synaptic growth ([@b52-molce-40-2-151]; [@b53-molce-40-2-151]) as well as fasciculation of axon tracts ([@b41-molce-40-2-151]), it is intriguing to hypothesize that loss of MAPK3 activity results in significant changes in the distribution of FasII, subsequently causing aberrant nerve innervation patterns. We have directly tested this idea by monitoring both transcriptional and translational levels of FasII. In contrast to our expectation, we failed to detect any significant changes in *fasII* transcripts or gene products in *rl* mutants, albeit mRNA levels diminished in some mutants affecting potential MAPK3-related network components ([Fig. 5C](#f5-molce-40-2-151){ref-type="fig"} and [Supplementary Table S3](#s1-molce-40-2-151){ref-type="supplementary-material"}). Taken together, our results indicate a minor or limited contribution of FasII to aberrant nerve innervation patterns observed in *rl* and other relevant mutants and suggest yet unknown alternative molecular mechanisms underlying MAPK3-dependent synaptic targeting.

Studies on molecular mechanisms of ASD have revealed consistent defects in other synaptic proteins, including Neuroligin (NLG), Neurexin (NRX) and SHANK family proteins in ASD patients and animal models (see [@b17-molce-40-2-151] for a recent review). Presynaptic NRXs bind to appropriate postsynaptic NLGs to form a trans-synaptic complex and to promote formation and stabilization of the synapse ([@b17-molce-40-2-151]). A recent report has further confirmed a coordination among NRX, NLG, and Wishful Thinking as important for controlling synaptic architecture and growth at NMJs ([@b6-molce-40-2-151]). In addition to NLG and NRX, SHANK family members are postsynaptic scaffolding proteins that play a critical role in dendritic spine morphogenesis and synaptic plasticity. For example, overexpression and knockdown of SHANK3, one of the SHANK family members, induce changes in dendritic spine morphology in opposite directions ([@b9-molce-40-2-151]). Considering their association with ASD, these data together strongly support the idea that synaptic abnormalities induced by dysfunction of NLG, NRX, and SHANK can predispose affected individuals to ASD. However, it should be noted that altered synapse morphology caused by the loss of NLG, NRX, and SHANK is qualitatively different from the aberrant nerve innervation and defasciculation patterns we observed in *rl* mutants. Furthermore, the presence of functional networks that link MAPK3 to NLG-NRX-SHANK has not been confirmed in experimental settings. Therefore, it is unlikely that MAPK3-dependent synaptic targeting process is directly associated with activity of the NLG-NRX-SHANK protein complex. Further studies are necesssary to completely rule out this possibility. Alternatively, unknown and novel molecular mechanisms other than NLG, NRX and SHANK may be activated by the MAPK3-associated protein complex to fine tune the selection of synaptic partners during development. Future studies employing genome-wide or proteomic approaches will shed new light on how synaptic targeting is precisely regulated in a MAPK3-dependent manner.

In summary, we report that the loss of Rolled MAPK3 located in the ASD-mapped 16p11.2 region induces an error in axon targeting and fasciculation. Similar errors can be detected in mutants defective in other proteins functionally associated with MAPK3, presumably via transcriptional regulation of MAPK3. Our findings provide a unique opportunity to study the contributions of individual genes located at ASD-linked CNV hotspots to the regulation of neuronal architecture, or more specifically, proper synaptic connectivity during development. Taking advantage of the well-defined stereotypic nature of synapses, future studies in *Drosophila* will continue to help to identify novel genetic factors that predispose individuals to ASD.
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![Aberrant innervation patterns of type III axons and premature axonal defasciculation in *rolled MAPK3* mutants\
(A) A mutation of *rolled* (or *rl*) cause morphologic changes at *Drosophila* larval NMJs, including ectopic targeting of type III axons to muscle 13 (arrow) and premature defasciculation of axon bundles at the boundary of muscles 13 and 12 (arrowheads), both of which are rarely detected in WT animals. Scale bar, 20 μm. (B, C) The frequency of ectopic type III axons (B) and premature axonal defasciculation (C) is shown for WT and *rl* larvae. The number of NMJs examined: WT, 102 and *rl*, 79. ^\*\*\*^, *P* \< 0.001, Fisher's exact test between WT and *rl.*](molce-40-2-151f1){#f1-molce-40-2-151}

![Phenotypic rescue of axon targeting and defasciculation errors by expression of wild-type *rolled* in presynaptic motor neurons and postsynaptic muscles\
(A) The *rl* mutant phenotypes, including ectopic targeting of type III axons to muscle 13 (arrow) and premature axonal defasciculation (arrowhead), are rescued by neuron- and muscle-specific expression of WT Rolled (*rl*^+^). The *elav^C155^*- and *mef2-GAL4* lines were used for neuron- and muscle-specific expression of a transgenic *rl*^+^ construct under the influence of *UAS* element, respectively. Scale bar, 20 μm. (B, C) The fraction of ectopic type III axons (B) and premature axonal defasciculation (C) is shown for each genotype. The fraction of mutant phenotypes observed in animals containing only a transgenic *rl*^+^ construct in the mutant background (*rl, UAS-rl^+^*) serves as a control, along with WT. The data from WT in [Fig. 1](#f1-molce-40-2-151){ref-type="fig"} are duplicated for comparisons. The number of NMJs examined for each genotype: WT, 102; *rl, UAS-rl^+^,* (no GAL4) 33; *elav^C155^-GAL4 → UAS-rl^+^*, 57; *mef2-GAL4 → UAS-rl^+^*, 55. ^\*\*\*^, *P* \< 0.001 for Fisher's exact test between WT and the genotype indicated*.* ^++^, *P* \< 0.01 and, ^+^, *P* \< 0.05 for Fisher's exact test between *rl, UAS-rl^+^* (no GAL4) and the genotype indicated*.*](molce-40-2-151f2){#f2-molce-40-2-151}

![Aberrant innervation patterns of type III axons observed in mutants defective in MAPK3-associated proteins\
(A) Ectopic targeting of type III axons to muscle 13 (arrows), a phenotype observed in *rl* mutants, is also detected in mutants defective in *Cdk2*, *Gα~q~* and *Gp93*. Scale bar, 20 μm. (B) The fraction of aberrant type III innervation patterns is shown for each genotype. The data from WT and *rl* groups in [Fig. 1B](#f1-molce-40-2-151){ref-type="fig"} are duplicated for comparisons. The number of NMJs examined: WT, 102; *rl*, 79; *Cdk2*, 35; *Gα~q~*, 35; *Gp93*, 40. ^\*\*\*^, *P* \< 0.001 and ^\*^*P* \< 0.05 for Fisher's exact test between WT and the genotype indicated*.*](molce-40-2-151f3){#f3-molce-40-2-151}

![Genetic interactions between *rolled* and genes encoding MAPK3-associated proteins\
(A) Double heterozygous larvae for both *rl* and one of the associated genes among *Cdk2*, *Gα~q~* and *Gp93* display frequently mistargeted type III axons in muscle 13 (arrows). Scale bar, 20 μm. (B) The fraction of aberrant type III innervation patterns is shown for single and double heterozygous combinations indicated. Upper (black) and lower (light gray) dashed lines represent the fraction observed in *rl* homozygous mutants and WT, respectively. The number of NMJs examined: *rl^−/+^*, 31; *Cdk2^−/+^*, 35; *rl^−/+^*; *Cdk2^−/+^*, 20; *Gα~q~^−/+^*, 36; *rl^−/+^*, *Cdk2^−/+^*, 24; *Gp93^−/+^*, 34; *rl^−/+^*; *Gp93^−/+^*, 20. ^\*^, *P* \< 0.05 for Fisher's exact test between *rl* single heterozygous (*rl^−/+^*) and corresponding double heterozygous mutants indicated. ^+++^, *P* \< 0.001 and ^+^, *P* \< 0.05 for Fisher's exact test between single and double heterozygous pairs indicated*.*](molce-40-2-151f4){#f4-molce-40-2-151}

![Transcriptional regulation of *rolled MAPK3* and *fasII* in *Cdk2*, *Gα~q~* and *Gp93* mutants*.*\
(A--C) The relative levels of mRNA estimated from qRT-PCR analyses with two independent *rl* primers (A, B) and a single fasII primer (C) are shown for each genotype. The level of mRNA in WT animals is used as a control to normalize the values measured from mutants. The levels of each mRNA are measured from at least three independent sets of triplicate samples. ^\*\*\*^, *P* \< 0.001, ^\*\*^, *P* \< 0.01 and ^\*^, *P* \< 0.05 for one-way ANOVA between WT and the genotype indicated, followed by Tukey's post-hoc test for pair-wise comparisons.](molce-40-2-151f5){#f5-molce-40-2-151}
